Word

NAVIN MOLECULAR

Status

Registered

Status Code

700

Status Date

Tuesday, September 6, 2022

Serial Number

79308808

Registration Number

6835743

Registration Date

Tuesday, September 6, 2022

Mark Type

5000

Filing Date

Monday, December 21, 2020

Published for Opposition

Tuesday, June 21, 2022

Trademark Owner History

NAVIN FLUORINE INTERNATIONAL LIMITED. - Original Registrant

Classifications

5 Chemical preparations used in the manufacture of medicinal products, namely, for the treatment of central nervous system diseases, cancer, metabolic diseases, endocrine diseases, cardiovascular disease, immune system related diseases and disorders, infectious diseases, kidney diseases, liver diseases, gastrointestinal diseases, inflammatory diseases, oncologic disorders, skin diseases and disorders, respiratory diseases, allergic diseases, neurological disorders, pain and psychiatric disorder; chemical preparations for pharmaceuticals purposes, namely, for the treatment of central nervous system diseases, cancer, metabolic diseases, endocrine diseases, cardiovascular disease, immune system related diseases and disorders, infectious diseases, kidney diseases, liver diseases, gastrointestinal diseases, inflammatory diseases, oncologic disorders, skin diseases and disorders, respiratory diseases, allergic diseases, neurological disorders, pain and psychiatric disorder chemical preparations for medical purposes, namely, drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; chemical preparations for pharmaceuticals purposes for the treatment of central nervous system diseases, cancer, metabolic diseases, endocrine diseases, cardiovascular disease, immune system related diseases and disorders, infectious diseases, kidney diseases, liver diseases, gastrointestinal diseases, inflammatory diseases, oncologic disorders, skin diseases and disorders, respiratory diseases, allergic diseases, neurological disorders, pain and psychiatric disorder; medicinal and pharmaceutical preparations for the treatment of central nervous system diseases, cancer, metabolic diseases, endocrine diseases, cardiovascular disease, immune system related diseases and disorders, infectious diseases, kidney diseases, liver diseases, gastrointestinal diseases, inflammatory diseases, oncologic disorders, skin diseases and disorders, respiratory diseases, allergic diseases, neurological disorders, pain and psychiatric disorder; chemical preparations for veterinary purposes for the treatment of central nervous system diseases, cancer, metabolic diseases, endocrine diseases, cardiovascular disease, immune system related diseases and disorders, infectious diseases, kidney diseases, liver diseases, gastrointestinal diseases, inflammatory diseases, oncologic disorders, skin diseases and disorders, respiratory diseases, allergic diseases, neurological disorders, pain and psychiatric disorder; disinfectants; insecticides; germicides; pesticides; preparations for fungicides, herbicides and preparations for destroying vermin

The mark consists of the term "NAVIN" in stylized orange font above the term "MOLECULAR" in grey font.
The color(s) orange and grey is/are claimed as a feature of the mark.
"MOLECULAR"

Trademark Events

Jan 3, 2023

Final Decision Transaction Processed By Ib

Dec 12, 2022

Final Disposition Notice Sent To Ib

Dec 12, 2022

Final Disposition Processed

Dec 6, 2022

Final Disposition Notice Created, To Be Sent To Ib

Sep 6, 2022

Notice Of Registration Confirmation Emailed

Sep 6, 2022

Registered-Principal Register

Jun 21, 2022

Official Gazette Publication Confirmation E-Mailed

Jun 21, 2022

Published For Opposition

Jun 1, 2022

Notification Of Notice Of Publication E-Mailed

May 16, 2022

Approved For Pub - Principal Register

May 13, 2022

Teas/Email Correspondence Entered

May 13, 2022

Correspondence Received In Law Office

May 13, 2022

Teas Response To Office Action Received

Jan 27, 2022

Notification Of Non-Final Action E-Mailed

Jan 27, 2022

Non-Final Action E-Mailed

Jan 27, 2022

Non-Final Action Written

Jan 11, 2022

Previous Allowance Count Withdrawn

Dec 21, 2021

Withdrawn From Pub - Og Review Query

Dec 9, 2021

Assigned To Lie

Dec 8, 2021

Approved For Pub - Principal Register

Dec 6, 2021

Teas/Email Correspondence Entered

Dec 6, 2021

Correspondence Received In Law Office

Dec 6, 2021

Teas Response To Office Action Received

Jul 19, 2021

Refusal Processed By Ib

Jul 1, 2021

Non-Final Action Mailed - Refusal Sent To Ib

Jul 1, 2021

Refusal Processed By Mpu

Jun 22, 2021

Non-Final Action (Ib Refusal) Prepared For Review

Jun 21, 2021

Non-Final Action Written

Jun 21, 2021

Assigned To Examiner

Jun 16, 2021

Assigned To Examiner

Apr 20, 2021

Application Filing Receipt Mailed

Apr 16, 2021

New Application Office Supplied Data Entered In Tram

Apr 15, 2021

Sn Assigned For Sect 66a Appl From Ib